A. Speciality Films
B. Polymer & Chemicals
C. D2C Petcare business
A. Speciality Films
⚡️Aims to expand Speciality portfolio with a target of 80%+ revenue (currently 70%) by 2023 end.
⚡️20% growth targeted from BOPET line (from FY22-23)
⚡️29% ROCE and 39% ROE as at March 2022
B: Polymer & Chemicals
⚡️Masterbatch plant (1st line with 75% captive consumption & 25% outside sale).
⚡️It is a concentrated mixture of pigments & additives used for imparting specific desired properties & coloring in plastic which are further used in compounding.
⚡️It plans to produce all masterbatches for captive use and niche specialty focused for outside sale
⚡️Target to reach 10% of Company's consolidated revenue in 3-5 years from masterbatches with consistent 25% ROCE
Specialty Textile Chemicals
⚡️It has commercialized 56 products and has started supplies to 40+ customers.
⚡️Forayed into the FMCG industry with the launch of ‘Fabritizer’, a product which assures a 99.9% protection against viruses and bacteria on clothes.
⚡️Adhesive is planned to kick start from FY22
⚡️Target to reach 10% of Company's consolidated revenue in 3-5 years from specialty chemicals with consistent 25%-30% ROCE
C. D2C Petcare business
⚡️India is the fastest-growing pet markets (@22%) in the world and the market is projected to cross$500 million in 2020.
⚡️There has been growth in all categories namely pet food, grooming, pharmaceuticals, toys and accessories.
⚡️No large scale organized players in India offering end to end comprehensive solution to the customers
⚡️Launched Pet care in Q2, FY22 along with launch of website, 1st mobile van & its flagship stores under brand name “Zigly”
⚡️D2C Omni channel business model to address pets need at every stage of life.
⚡️Plans to launch 15-20 nos experience centers during FY23 and enhance online presence.
⚡️Plan to demerge Petcare vertical into separate company in medium term.
⚡️Transformation into primarily specialty films company with consistent 20%+ ROCE
⚡️20% revenue with 25%+ ROCE in about 5 years in
Specialty Chemicals
⚡️Build and demerge the business vertical in medium term to drive shareholders valuation in Petcare Business
A thread on Antony Waste Handling Cell Limited
(Managing Waste. Delivering Growth) #AWHCL#antonywaste
Before beginning, let understand the Importance of waste management in today’s world
1. The growing population is causing negative impact on our society. The current model of production & consumption generates a lot of waste that, in many cases, does not get reused or recycled.
2. Unmanaged or poorly managed waste contaminates the environment, harms both animals and humans, and can even affect the economic development of a region. It is quintessential part of a modern urban life.
Incorporated in 1978, Gland Pharma is an injectables-focused B2B player with capabilities for both API & formulations that derives 2/3rd of its revenue from the US, Row (16%) & India (9%).
Injectables account for 98% of its revenue while Ophthalmic fetches 2%. It is one of the fastest growing generic injectables-focused companies.
It offers services that cover entire injectables value-chain, including contract development, own development, dossier preparation & filing, technology transfer and manufacturing across a range of delivery systems.